ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements with these filters
Mono Pharmacare declares non-applicability of the Regulation 27(2) corporate governance report for Q2 FY2026-27, as its shares are SME-listed. The filing is a routine compliance exemption notice with no business event.
Mono Pharmacare notified non-applicability of its Q1 FY27 corporate governance report under Reg 27(2). As an SME-listed entity, it is exempt under Reg 15(2)(b) of SEBI LODR.
Mono Pharmacare Limited held its Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, auditor appointment, and related party transactions.
Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.
Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.
Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.
Mono Pharmacare Limited's board meeting approved the re-appointment of a director, the appointment of new statutory auditors, and the scheduling of the company's 4th AGM.
Mono Pharmacare Limited has scheduled a board meeting for September 3, 2026, to discuss other business matters.
Mono Pharmacare Limited has appointed M/s. B G Kalal & CO as Internal Auditor for FY 2026-27. The board approved this based on Audit Committee recommendations.
Mr. Rahul Joshi resigned as Company Secretary and Compliance Officer effective July 1, 2026. The resignation cited pending salary dues and non-payment of salary.
Mono Pharmacare approved FY2026 audited financial results and appointed new internal and secretarial auditors. The company also noted the resignation of Company Secretary Rahul Joshi.
Mono Pharmacare scheduled a board meeting on July 09, 2026. The board will consider audited annual financial results for March 2026.
Mono Pharmacare paid a ₹9,676 fine for SEBI Regulation 31 non-compliance. The Board noted the lapse and directed stronger compliance controls.
Mono Pharmacare held an EGM on June 30, 2026. The meeting approved the appointment of a Statutory Auditor and Independent Director.
Mono Pharmacare Limited has convened an EGM on June 30, 2026. Shareholders will vote on appointing M/s. R K Mergu & Co. as auditors and regularizing Ms. Nirmala Ranawat's appointment.
Mono Pharmacare's board approved the appointment of Nirmala Ranawat as Independent Director and reconstituted various committees. The board also decided to convene an Extraordinary General Meeting.
Mono Pharmacare Limited filed a non-applicability confirmation for quarterly corporate governance reports. As an SME-listed entity, it remains exempt from Regulation 27(2) compliance requirements.
Mono Pharmacare Limited has received consent from Ms. Nirmala Ranawat for her appointment as an Independent Director. Her professional background includes extensive corporate law and taxation experience.
Mono Pharmacare Limited has scheduled a Board Meeting for June 03, 2026. The meeting will primarily address other business matters as per the agenda.